WallStreetZenWallStreetZen

NASDAQ: NBIX
Neurocrine Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NBIX

Based on 17 analysts offering 12 month price targets for Neurocrine Biosciences Inc.
Min Forecast
$110.00-3.29%
Avg Forecast
$129.71+14.04%
Max Forecast
$154.00+35.4%

Should I buy or sell NBIX stock?

Based on 17 analysts offering ratings for Neurocrine Biosciences Inc.
Strong Buy
Strong Buy
9 analysts 52.94%
Buy
4 analysts 23.53%
Hold
4 analysts 23.53%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NBIX stock forecasts and price targets.

NBIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Canaccord Genuity
Bottom 9%
9
Strong BuyMaintains$144.00+26.60%2023-09-13
Mizuho
Bottom 7%
7
HoldReiterates$113.00-0.65%2023-09-13
Wedbush
Bottom 4%
4
BuyMaintains$137.00+20.45%2023-09-13
JP Morgan
Bottom 3%
3
Strong BuyMaintains$134.00+17.81%2023-09-13
Cantor Fitzgerald
Top 6%
95
Strong BuyReiterates$136.00+19.57%2023-09-13
BMO Capital
Bottom 12%
12
HoldMaintains$111.00-2.41%2023-09-13
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$146.00+28.36%2023-09-13
Oppenheimer
Top 5%
96
BuyMaintains$154.00+35.40%2023-08-21
RBC Capital
Top 8%
93
HoldMaintains$110.00-3.29%2023-08-02
Morgan Stanley
Bottom 19%
19
Strong BuyReiterates$130.00+14.30%2023-08-02

1 of 2

Forecast return on equity

Is NBIX forecast to generate an efficient return?
Company
N/A
Industry
0.08%
Market
28.82%

Forecast return on assets

Is NBIX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.05%

NBIX earnings growth forecast

How is NBIX forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
59.03%
Industry
26.62%
Market
20.24%
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NBIX revenue growth forecast

How is NBIX forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
11.83%
Industry
13.25%
Market
8.15%
NBIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NBIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NBIX vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
NBIX$113.74$129.71+14.04%Strong Buy
RDY$66.50$70.00+5.26%Strong Buy
VTRS$9.64$11.00+14.11%Strong Sell
TEVA$10.35$12.00+15.94%Buy
CTLT$45.34$50.67+11.75%Buy
View Top Pharmaceutical Stocks

Neurocrine Biosciences Stock Forecast FAQ

Is Neurocrine Biosciences Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 17 Wall Street analysts covering (NASDAQ: NBIX) stock is to Strong Buy NBIX stock.

Out of 17 analysts, 9 (52.94%) are recommending NBIX as a Strong Buy, 4 (23.53%) are recommending NBIX as a Buy, 4 (23.53%) are recommending NBIX as a Hold, 0 (0%) are recommending NBIX as a Sell, and 0 (0%) are recommending NBIX as a Strong Sell.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.

What is NBIX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: NBIX) forecast ROE is N/A, which is considered weak.

What is NBIX's Price Target?

According to 17 Wall Street analysts that have issued a 1 year NBIX price target, the average NBIX price target is $129.71, with the highest NBIX stock price forecast at $154.00 and the lowest NBIX stock price forecast at $110.00.

On average, Wall Street analysts predict that Neurocrine Biosciences's share price could reach $129.71 by Sep 13, 2024. The average Neurocrine Biosciences stock price prediction forecasts a potential upside of 14.04% from the current NBIX share price of $113.74.

What is NBIX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: NBIX) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.05%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.